16 January 2025
Cancers | Highly Viewed Papers in 2024 and Hot Topic Special Issues on Cancer Biomarkers

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to share some highly viewed papers on cancer biomarkers that were published in the journal Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.
1. “Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis”
by Taha Koray Sahin, Alessandro Rizzo, Sercan Aksoy and Deniz Can Guven
Cancers 2024, 16(10), 1835; https://doi.org/10.3390/cancers16101835
Available online: https://www.mdpi.com/2072-6694/16/10/1835
2. “Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy”
by Chloe Springer, Danish Humayun and Rachid Skouta
Cancers 2024, 16(3), 647; https://doi.org/10.3390/cancers16030647
Available online: https://www.mdpi.com/2072-6694/16/3/647
3. “Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma”
by Lena Nanz, Ulrike Keim, Alexander Katalinic, Thomas Meyer, Claus Garbe and Ulrike Leiter
Cancers 2024, 16(3), 606; https://doi.org/10.3390/cancers16030606
Available online: https://www.mdpi.com/2072-6694/16/3/606
4. “Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?”
by Maria Cecília Mathias-Machado, Victor Hugo Fonseca de Jesus, Alexandre Jácome, Mauro Daniel Donadio, Marcelo Porfirio Sunagua Aruquipa, João Fogacci, Renato Guerino Cunha, Leonard Medeiros da Silva and Renata D’Alpino Peixoto
Cancers 2024, 16(3), 679; https://doi.org/10.3390/cancers16030679
Available online: https://www.mdpi.com/2072-6694/16/3/679
5. “ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer”
by Aakash Desai, Tadana A. Vázquez, Keishla M. Arce, Marcelo Corassa, Philip C. Mack, Jhanelle E. Gray and Bruna Pellini
Cancers 2024, 16(5), 940; https://doi.org/10.3390/cancers16050940
Available online: https://www.mdpi.com/2072-6694/16/5/940
6. “Upper Tract Urothelial Cancer: Guideline of Guidelines”
by Savio Domenico Pandolfo, Simone Cilio, Achille Aveta, Zhenjie Wu, Clara Cerrato, Luigi Napolitano, Francesco Lasorsa, Giuseppe Lucarelli, Paolo Verze, Salvatore Siracusano et al.
Cancers 2024, 16(6), 1115; https://doi.org/10.3390/cancers16061115
Available online: https://www.mdpi.com/2072-6694/16/6/1115
Special Issues:
“Views and Perspectives of Cutaneous Squamous Cell Carcinoma”
Guest Editors: Dr. Thomas Meyer and Dr. Alexandra Geusau
Viewed by: 24770+
Submission deadline: 30 June 2025
“Novel Biomarkers in Non-Small Cell Lung Cancer (NSCLC)”
Guest Editor: Dr. Alfredo Tartarone
Viewed by: 20730+
Submission deadline: 30 June 2025
“Pre-Clinical Studies of Personalized Medicine for Cancer Research”
Guest Editor: Dr. Nuno Vale
Viewed by: 35200+
Submission deadline: 30 June 2025
“Predictive Biomarkers for Colorectal Cancer”
Guest Editor: Dr. Mitsukuni Suenaga
Viewed by: 19910+
Submission deadline: 21 March 2025
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office